Search research articles
Contact Us
Filters
Showing results (251-260 of 312) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial
Peter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.
Oncotarget
|
November 9, 2016
CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells
Christian B Schiller, Todd A Braciak, Nadja C Fenn, et al.
Bone Marrow Transplantation
|
March 5, 2020
Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC)
Bruce Morland, Tomas Kepak, Sandro Dallorso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Peter Bader, Hermann Kreyenberg, Walter Hoelle, et al.
Cancer Immunology, Immunotherapy : CII
|
January 19, 2024
Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3
Thomas Eichholz, Florian Heubach, Anne-Marie Arendt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 7, 2016
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody
Ursula Jördis Eva Seidel, Patrick Schlegel, Ludger Grosse-Hovest, et al.
Blood
|
January 25, 2015
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT
Judith Feucht, Kathrin Opherk, Peter Lang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 18, 2018
Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016
Monzr M Al Malki, Richard Jones, Qing Ma, et al.
British Journal of Haematology
|
December 6, 2017
CD34<sup>+</sup> selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation
Chiara Mainardi, Martin Ebinger, Sigrid Enkel, et al.
Frontiers in Oncology
|
May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy
Sebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 312) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial
Peter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.
Oncotarget
|
November 9, 2016
CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells
Christian B Schiller, Todd A Braciak, Nadja C Fenn, et al.
Bone Marrow Transplantation
|
March 5, 2020
Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC)
Bruce Morland, Tomas Kepak, Sandro Dallorso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2004
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Peter Bader, Hermann Kreyenberg, Walter Hoelle, et al.
Cancer Immunology, Immunotherapy : CII
|
January 19, 2024
Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3
Thomas Eichholz, Florian Heubach, Anne-Marie Arendt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 7, 2016
Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody
Ursula Jördis Eva Seidel, Patrick Schlegel, Ludger Grosse-Hovest, et al.
Blood
|
January 25, 2015
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT
Judith Feucht, Kathrin Opherk, Peter Lang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 18, 2018
Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016
Monzr M Al Malki, Richard Jones, Qing Ma, et al.
British Journal of Haematology
|
December 6, 2017
CD34<sup>+</sup> selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation
Chiara Mainardi, Martin Ebinger, Sigrid Enkel, et al.
Frontiers in Oncology
|
May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy
Sebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.
Page
of 32